role of telehealth services in the treatment of rare disease: analysis of 1 year of work on the example of anal cancer
https://doi.org/10.17650/2686-9594-2020-10-2-28-32
Abstract
Objective: to assess the potential need for telehealth consultations in regions for the treatment of patients diagnosed with anal cancer and to analyze the most common treatment errors.
Materials and methods. We analyzed telehealth consultations provided for 3 Federal districts between April 2019 and April 2020. The following parameters were evaluated: the ratio between the predicted need for telehealth consultations and the real number of requests, the number of medical errors in patients who had already undergone first and / or subsequent treatment stages (according to relevant clinical guidelines).
Results. Fifteen telehealth consultations were provided during this year: 13 of them (86.7 %) for disease progression or complications and 2 of them (13.3 %) to determine the initial treatment strategy. Treatment errors were registered in 11 out of 13 cases (84.6 %). The predicted need based on the population size was 565 consultations per year; the predicted need based on the real number of patients visited cancer clinics was 81 consultations.
Conclusions. We found many significant errors in treatment regimens of patients with squamous cell anal carcinoma. Wider use of telehealth consultations with Federal centers will ensure the correct choice of the initial treatment strategy.
About the Authors
S. S. Gordeev
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
M. Yu. Fedyanin
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
E. V. Glazkova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
V. A. Amosova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
A. V. Petrovskiy
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
Russian Federation
24 Kashirskoe Shosse; Moscow 115478
References
1. Борисов А. Комментарий к Конституции Российской Федерации (постатейный) с комментариями Конституционного суда РФ. Litres, 2020. [Borisov A. Comment to the Constitution of the Russian Federation (article-by-article) with comments of the Constitutional Court of the Russian Federation. Litres, 2020. (In Russ.)].
2. Raine R., Fitzpatrick R., Barratt H. et al. Challenges, solutions and future directions in the evaluation of service innovations in health care and public health. Southampton, 2016.
3. Hart J.T. The inverse care law. Lancet 1971;1(7696):405–12. DOI: 10.1016/s0140-6736(71)92410-x.
4. Суринов А., Баранов Э., Безбородова Т. Россия в цифрах. 2018: краткий статистический сборник. Росстат, 2018. [Surinov A., Baranov E., Bezborodova T. Russia in figures. 2018: brief statistical compendium. Rosstat, 2018. (In Russ.)].
5. Гордеев С.С., Мамедли З.З., Федянин М.Ю., Черных М.В. Клинические рекомендации. Плоскоклеточный рак анального канала, анального края, перианальной кожи. Ассоциация онкологов России, 2009. C. 67. Доступно по: https://oncology-association.ru/files/ clinical-guidelines-2020/rak_analnogo_ kanala.pdf. [Gordeev S.S., Mamedli Z.Z., Fedyanin M.Yu., Chernykh M.V. Clinical guidelines. Squamous cell carcinoma of the anal canal, anal margin, and perianal skin. Association of Russian Oncologists, 2009. P. 67. Available at: https://oncology-association.ru/files/ clinical-guidelines-2020/rak_analnogo_ kanala.pdf. (In Russ.)].
6. Islami F., Ferlay J., Lortet-Tieulent J. et al. International trends in anal cancer incidence rates. Int J Epidemiol 2017;46(3): 924–38. DOI: 10.1093/ije/dyw276.
7. Gunderson L.L., Winter K.A., Ajani J.A. et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/ mitomycin versus fluorouracil/cisplatin. J Clin Oncol 2012;30(35):4344–51. DOI: 10.1200/JCO.2012.43.8085.
8. James R.D., Glynne-Jones R., Meadows H.M. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, openlabel, 2 × 2 factorial trial. Lancet Oncol 2013;14(6):516–24.
9. Gordeyev S.S., Rasulov A.O., Gorbounova V.A. et al. Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma. Cancer Chemother Pharmacol 2017;80(3):623–9. DOI: 10.1007/s00280-017-3408-4.
10. Arcadipane F., Franco P., Ceccarelli M. et al. Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. Asia Pac J Clin Oncol 2018;14(3):217–23.
11. Mitra D., Hong T.S., Horick N. et al. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol 2017;2(2):110–7. DOI: 10.1016/j.adro.2017.01.009.
12. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019. C. 250. [Malignant tumors in Russia in 2018 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2019. P. 250. (In Russ.)].
13. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002;49(3):194–209. 14. Nakashima J., Zulfiqar H. Embryology, rectum and anal canal. Treasure Island: StatPearls Publishing, 2020.
Review
Views:
650
Email this article 